| Literature DB >> 26451089 |
Ravindra M Samarth1, Meenakshi Samarth2, Yoshihisa Matsumoto3.
Abstract
Systematic biological measurement of "cytogenetic endpoints" has helped phenomenally in assessment of risks associated with radiation exposure. There has been a surge in recent times for the usage of radioactive materials in health care, agriculture, industrial, and nuclear power sectors. The likelihood of radiation exposure from accidental or occupational means is always higher in an overburdened ecosystem that is continuously challenged to meet the population demands. Risks associated with radiation exposure in this era of modern industrial growth are minimal as international regulations for maintaining the safety standards are stringent and strictly adhered to, however, a recent disaster like "Fukushima" impels us to think beyond. The major objective of radiobiology is the development of an orally effective radio-modifier that provides protection from radiation exposure. Once available for mass usage, these compounds will not only be useful for providing selective protection against accidental and occupational radiation exposure but also help to permit use of higher doses of radiation during treatment of various malignancies curtailing unwarranted adverse effects imposed on normal tissues. Bio-active compounds isolated from natural sources enriched with antioxidants possess unique immune-modulating properties, thus providing a double edged benefit over synthetic radioprotectors. We aim to provide here a comprehensive overview of the various agents originating from plant sources that portrayed promising radioprotection in various experimental models with special emphasis on studies that used cytogenetic biomarkers. The agents will include crude extracts of various medicinal plants, purified fractions, and herbal preparations.Entities:
Keywords: cytogenetic biomarkers; medicinal plants; radiation exposure; radioprotectors
Mesh:
Substances:
Year: 2015 PMID: 26451089 PMCID: PMC4590411 DOI: 10.2147/DDDT.S91299
Source DB: PubMed Journal: Drug Des Devel Ther ISSN: 1177-8881 Impact factor: 4.162
Tools for assessment of radiation injury using cytogenetic biomarkers
| Cytogenetic biomarkers | Particulars | References |
|---|---|---|
| Total number of aberrations | The radiation damage is quantified by scoring different types of chromosomal aberrations, and is considered to be one of the accurate technique among cytogenetic tools used as biological dosimeter. This technique is used to estimate the dose–response curves and is also popular in radiation biology for radioprotective studies. | |
| Dicentrics and ring chromosomes | For assessment of radiation exposure, biological dosimetry utilizing dicentric chromosomes analysis in human lymphocytes is a well-known method practiced since long ago, along with physical dosimetry for radiation dose assessment in potentially overexposed people as well as for suspected exposures to estimate risk of health effects. | |
| Micronuclei assay/cytokinesis-block micronucleus assay | Micronuclei, small satellite structures, are the chromosomal fragments lacking centromeres. The frequency of micronuclei is variously used as cytogenetic biomarker. The cytokinesis-block micronucleus assay is simple in terms of scoring criteria and is a reliable and sensitive cytogenetic biomarker. | |
| Sister chromatid exchanges | Many authors have documented that cells exposed to radiation had significant increase in sister chromatid exchanges. | |
| Translocations | Irradiation causes various types of DNA damage that lead to stable chromosomal aberration. Translocation chromosomal aberration is stable and can be used as biological dosimetry for dose assessment. | |
| Premature chromosome condensation | The premature chromosome condensations assay is being used for biological dosimetry following radiation exposures. The main advantage of the premature chromosome condensations assay is that there is no need for cells to divide for evaluation of cytogenetic damage. | |
| FISH/chromosome painting/mBAND analysis | A relatively newly developed technique, FISH has revealed unique endpoints related to radiation quality. It has now become possible to detect inter-chromosomal and intra-chromosomal exchanges as well as distribution of the breakpoints of aberrations with the help of mBAND technique. | |
| DNA-PK | Double-strand break repair pathways are responsible for maintaining genomic integrity, genetic instability, and neoplastic transformation. It has been speculated that DNA-PK plays an essential role in DNA double-strand break repair and maintaining genomic integrity. | |
| hTERT (telomerase reverse transcriptase) and genomic instability | The hTERT-immortalized cells have been found to be useful for determining the effects of radiation. | |
| Cytokinesis-block micronucleus cytome assay | Development of microarray formats analysis of the chromosomal damage of human peripheral lymphocytes is done with the modern technology of integration of techniques. The cytokinesis-block micronucleus cytome assay is being utilized as radiation biological dosimetry specifically developed to assess various forms of chromosomal damage. | |
| The single cell gel electrophoresis assay/comet assay | The single cell gel electrophoresis or comet assay, developed for the evaluation of DNA single-strand breaks utilizes DNA migration as a measure of the DNA damage, however, the DNA double-strand breaks can be measured by neutral comet assay. | |
Abbreviations: FISH, fluorescence in situ hybridization; mBAND, high resolution multicolor chromosome banding.
Modulation of radiation-induced cytogenetic damage by various medicinal plants
| Name of plant | Family | Doses
| Animal/tissue studied | Cytogenetic parametersstudied | References | |
|---|---|---|---|---|---|---|
| Plant extract dose | Radiation dose | |||||
| Acanthaceae | 800 mg/kg bwt orally | 8 Gy | Mouse bone marrow cells | Chromosomal aberrations | ||
| Rutaceae | 1.25–100 μg/mL treatment in culture | 3 Gy | Human peripheral blood lymphocytes | Micronuclei frequency | ||
| Apocynaceae | 100 mg/kg bwt orally | 2.5 Gy | Mouse bone marrow cells | Chromosomal damage and micronuclei | ||
| Amaryllidaceae | 25–500 mg/kg bwt orally | 0.5, 1, and 2 Gy Mitomycin C 1.5 mg/kg bwt ip | Mouse bone marrow cells | Micronucleus test | ||
| Meliaceae | 7.5 mg/kg bwt orally | 1–5 Gy | Mouse bone marrow cells | Chromosomal aberrations | ||
| Brassicaceae | 50–250 mg/kg bwt orally | 0.5–4 Gy | Mouse bone marrow cells | Micronuclei frequency | ||
| Oxalidaceae | 50 mg/kg bwt ip | 6 Gy | Swiss albino mice | Hemopoietic damage and immunomodulation | ||
| Bixaceae | 500–1,000 mg/kg bwt ip | 2 and 4 Gy | Mouse bone marrow cells | Chromosomal aberrations | ||
| Rutaceae | 250 mg/kg ip | 1.5 Gy | Mouse bone marrow cells | Clastogenic effect | ||
| Lamiaceae | 5 μg/mL treatment in culture | 0.5, 1, 2, and 4 Gy | V79 cells | Clastogenic effect | ||
| Rosaceae | 200 mg/kg bwt ip | 2 Gy | Mouse bone marrow cells | Frequency of MnPCE | ||
| Fabaceae | 0.3–2.5 gm/kg bwt ip | Cyclophosphamide | Mouse bone marrow cells | Chromosomal aberrations | ||
| 20 mg/kg bwt ip | ||||||
| Poaceae | 40 and 50 μg/mL treatment in culture | 0.5, 1, 2, 3, and 4 Gy | V79 cells and human | Micronuclei frequency | ||
| Ginkgoaceae | 100 μg/mL treatment in culture | γ-radiation | Whole blood from healthy volunteers | The anticlastogenic effect | ||
| Gesneriaceae | 1.0, 4.0, and 8.0 μL/mL treatment in culture | 2 Gy | Rabbit peripheral lymphocytes | Chromosomal aberrations | ||
| Elaeagnaceae | 25–35 mg/kg bwt ip | 2 Gy | Mouse bone marrow cells | Micronuclei frequency | ||
| Anacardiaceae | 50–1,000 μg/mL treatment in culture | 5 Gy | Human lymphocytes | DNA damage, DNA repair/comet assay | ||
| Lamiaceae | 1 g/kg bwt orally | 8 Gy | Mouse bone marrow cells | Chromosomal aberrations/micronuclei frequency/EPO level | ||
| Moringaceae | 150 mg/kg bwt ip | 4 Gy | Mouse bone marrow cells | Percent aberrant cells Micronucleated cells | ||
| Nelumbonaceae | 200 mg/kg bwt ig | 4 Gy | Mouse bone marrow cells | DRF, CFU-S, MnPCE, NCE, and P/N ratio | ||
| Ranunculaceae | 0–100 mg/kg bwt orally | 2 Gy | Mouse splenic lymphocytes | Micronuclei frequency | ||
| Lamiaceae | 10 mg/kg bwt ip | 1–6 Gy | Mouse bone marrow cells | Percent aberrant cells | ||
| Araliaceae | 100, 200, or 300 mg/kg bwt ip | 1.5 Gy | Mouse bone marrow cells | Frequency of MnPCE PCE/NCE ratio | ||
| Araliaceae | 50–1,000 μg/mL treatment in culture | 1 and 2 Gy | Human peripheral blood lymphocytes | Micronuclei frequency | ||
| Phyllanthaceae | 50–250 mg/kg bwt ip | 4 Gy | Mouse bone marrow cells | Chromosomal aberrations | ||
| Berberidaceae | 200 mg/kg bwt im | 9 Gy | Mice strain “A” | Micronuclei frequency | ||
| Plumbaginaceae | 5 mg/kg bwt ip | 2 Gy | Swiss albino mice | CFU-S | ||
| Lichinaceae | 1–5 mg/g bwt orally | 2.5 Gy | Mouse bone marrow cells | Micronuclei frequency | ||
| Solanaceae | 30 mg/kg bwt ip | 2 Gy | Swiss albino mice | CFU-S | ||
Abbreviations: ig, intra-gastric administration; im, intramuscular injection; ip, intraperitoneal injection; bwt, body weight; CFU-S, colony forming units in spleen; MnPCE, micronucleated polychromatic erythrocytes; EPO, erythropoietin level; DRF, dose reduction factor; NCE, normochromatic erythrocytes; P/N, ratio of polychromatic and normochromatic erythrocytes; PCE, polychromatic erythrocytes.
Modulation of radiation-induced cytogenetic damage by various phytochemicals and herbal formulations
| Name of phytochemical | Chemical/other name | Origin/source | Doses
| Animal/tissue studied | Cytogenetic parameters studied | References | |
|---|---|---|---|---|---|---|---|
| Phytochemical dose | Radiation dose | ||||||
| Apigenin | 4′,5,7-trihydroxyflavone or 5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | Plants | 0, 2.5, 5, 10, and 25 μg/mL treatment in culture | 2 Gy | Human peripheral blood lymphocytes | Micronuclei frequency | |
| Beta carotene | 1,3,3-Trimethyl-2-[3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-1-ene | Plants and fruits | 0.5 and 2.5 mg/kg bwt orally | 1.15 Gy | Mouse bone marrow cells | Micronuclei frequency | |
| Caffeine | 1,3,7-Trimethylpurine-2,6-dione | Coffee seeds, tea | Caffeine treatment in culture | 1.75 and 4.38 Gy | V79 cells | Aberrations per cell | |
| Chlorophyllin | Natural green 3, E141 | Green leafy vegetables | 50, 100, and 200 mg/kg bwt orally | 1.15 Gy | Mouse bone marrow cells | Micronuclei frequency | |
| Chlorogenic acid | (1 | Bamboo, potato, and many other plants | 50, 100, and 200 mg/kg bwt orally | 1.15 Gy | Mouse bone marrow cells | Micronuclei frequency | |
| Curcumin | (1 | Rhizome of | 5, 10, and 20 mg/kg bwt orally | 1.15 Gy | Mouse bone marrow cells | Micronuclei frequency | |
| Eugenol | 4-Allyl-2-methoxyphenol | Basil, cinnamon, clove oil, nutmeg | 75, 150, and 300 mg/kg bwt orally | 0.5, 1, 1.5, and 2 Gy | Mouse bone marrow cells | Micronuclei frequency | |
| Hesperidin | (2 | Citrus fruit | 10, 20, 40, 80, and 160 mg/kg bwt, ip 3.27, 6.55, 9.83, 13.10, 16.38, and 19.65 μM treatment in culture | 2 Gy | Mouse bone marrow cells | Micronuclei frequency PCE/PCE + NCE ratio Micronuclei frequency, dicentric aberration, comet assay, DNA fragmentation assay | |
| Lycopene | (6 | Tomatoes, red fruits, red carrots, papaya, and watermelons | 0.001–0.020 μM treatment in culture | 10 Gy | Human peripheral blood lymphocytes | Mitotic index frequency of chromosomal aberrations | |
| Mangiferin | (1S)-1,5-anhydro-1-(1,3,6,7-tetrahydroxy-9-oxo-9H-xanthen-2-yl)-D-glucitol | Mangoes, | 0–100 μg/mL treatment in culture | 0, 1, 2, 3, or 4 Gy | Human peripheral blood lymphocytes | Micronucleated binucleated cell frequency proliferation index DNA damage/repair; comet assay | |
| Melatonin | Found in animals, plants, fungi, and bacteria | 2.5 mg/kg bwt ip | 4.0 Gy | Mouse bone marrow cells | Mitotic index, MnPCEs, chromosomal aberrations | ||
| Naringin | 7-[[2- | Grapefruit, citrus fruits | 2 mg/kg bwt ip | Different doses | Mouse bone marrow cells | Frequencies of aberrant cells, chromosomal aberrations | |
| Orientin | 8-C-β-D-glucopyranosyl-luteolin or 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2 | 50 μg/kg bwt ip | 0–6 Gy | Mouse bone marrow cells | CFU-S, chromosomal aberrations | ||
| Propolis | Propolis had approximately 50 constituents, primarily resins and vegetable balsams (50%), waxes (30%), essential oils (10%), and pollen (5%) | Resinous mixture collected by honey bees from tree buds, sap flow, or other plants | 20–2,000 μg/mL treatment in culture | 2 Gy | Human peripheral blood | Frequency of chromosomal aberrations, frequency of dicentrics Leukocyte count, spleen’s plaque-forming activity | |
| Quercetin | 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4 | Oak tree and red onions | 3, 6, 12, 24, and 48 μM treatment in culture | 1–4 Gy | Human peripheral blood lymphocytes | Micronuclei frequency, dicentric aberration, comet assay Chromosomal aberrations, micronuclei frequency, comet assay | |
| Resveratrol | 3,5,4′-Trihydroxy-trans-stilbene | Naturally produced by several plants in response to injury, also found in grapes, blueberries, raspberries, and mulberries | 100 mg/kg bwt, orally | 3 Gy | Mouse bone marrow cells | Total chromosomal aberration frequency per metaphase | |
| Rutin | 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-[α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranosyloxy]-4 | Orange, lemon, lime, grapefruit, and berries | 10–20 mg/kg bwt orally | 3 Gy | Swiss albino mice | Chromosomal aberrations, micronuclei frequency, comet assay | |
| Turmeric | Diferuloylmethane, demethoxycurcumin, and bisdemethoxycurcumin | 100, 250, and 500 μg/mL treatment in culture | 2.5 Gy | CHO cells | Frequencies of chromosomal aberrations | ||
| Vanillin | 4-Hydroxy-3-methoxybenzaldehyde | Seed and pods of | 5, 50 or 100 μg/mL treatment in culture | 1–12 Gy | V79 cells | Micronucleated binucleated cells, aberrant cells | |
| Vicenin | 6-C-β-D-xylopyranosyl-8-C-β-D-glucopyranosylapigenin | 50 μg/kg bwt ip | 0–6 Gy | Mouse bone marrow cells | CFU-S chromosomal aberrations | ||
| Vinblastine | Dimethyl (2β,3β,4β,5α,12β,19α)-15-[(5 | 0.05 mg/kg bwt ip | 1–4 Gy | Mouse bone marrow cells | Micronuclei frequency, P/N ratio | ||
| Vitamin C | 2-Oxo-L-threo-hexono-1,4-lactone-2,3-enediol or ( | Plants, fruits, and vegetables | 1 μg/mL treatment in culture | 2 Gy | Human peripheral blood lymphocytes | Micronuclei frequency | |
| Vitamin E | (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-(4,8,12-trimethyltridecyl)]-6-chromanol | Wheat germ oil, sunflower oil, safflower oil, corn oil, soybean oil, and margarine | 2 μg/mL treatment in culture | 2 Gy | Human peripheral blood lymphocytes | Micronuclei frequency | |
| Zingerone | 4-(4-Hydroxy-3-methoxyphenyl)-2-butanone | Cooked ginger | 20 mg/kg bwt orally | 1–4 Gy | Swiss albino mice | CFU-S, MnPCE, NCE and PCE/NCE ratio | |
| Abana | 5, 10, and 20 mg/kg bwt ip | 0–3 Gy | Mouse bone marrow cells | Micronuclei frequency, PCE/NCE ratio | |||
| Brahma Rasayana | 50 mg/day orally | Radio/chemotherapy | Cancer patients | Total leukocytes, lymphocytes, and neutrophils | |||
| Liv. 52 | 500 mg/kg bwt orally | 4.5 Gy | Mouse bone marrow cells | Frequency of chromatid and chromosomal aberrations | |||
Abbreviations: ip, intraperitoneal injection; bwt, body weight; CHO, Chinese hamster ovary; PCE, polychromatic erythrocytes; NCE, normochromatic erythrocytes; MnPCE, micronucleated polychromatic erythrocytes; CFU-S, colony forming units in spleen; P/N, ratio of polychromatic to normochromatic erythrocytes.